Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
OnKure Therapeutics, Inc. (OKUR) had Pre-Tax Income of $-15.35M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-15.35M |
|
-- |
|
-- |
|
$16.90M |
|
$-16.90M |
|
$1.55M |
|
|
Pre-Tax Income |
$-15.35M |
$-15.35M |
|
$-15.35M |
|
$-15.35M |
|
$-15.35M |
|
$-15.35M |
|
$-16.90M |
|
$-16.71M |
|
49.87M |
|
49.87M |
|
$-0.31 |
|
$-0.31 |
|
| Balance Sheet Financials | |
$177.68M |
|
$0.43M |
|
$1.68M |
|
$179.35M |
|
$6.64M |
|
-- |
|
$0.60M |
|
$7.25M |
|
$172.11M |
|
$172.11M |
|
$172.11M |
|
40.50M |
|
| Cash Flow Statement Financials | |
$-23.29M |
|
$-9.88M |
|
$140.62M |
|
$59.05M |
|
$166.50M |
|
$107.45M |
|
$5.83M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
26.75 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-23.30M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-8.92% |
|
-8.92% |
|
-8.56% |
|
-8.92% |
|
$4.25 |
|
$-0.47 |
|
$-0.47 |
|